Stingeze
Product Images NDC 68093-7151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Stingeze (NDC 68093-7151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wisconsin Pharmacal Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (C3312w)

FDA Label Image

Card Label (D3312w)

Card Label (D3312w)
This is a drug facts label for a product that contains Benzocaine, Phenol, and Camphor. It asserts that it is an analgesic, anesthetic, and antipruritic first aid antiseptic. The label warns users against getting the product in their eyes or applying it over large areas of their body. It also instructs users to contact a medical professional for deep or puncture wounds, or severe burns. The label provides directions for use, frequency of use, and ingredients, and warns users against using the product for more than seven days. It further cautions users to keep the product out of reach of children and to seek medical help if swallowed. The product is marketed as providing maximum relief for bites and stings caused by mosquitoes, bees, wasps, fire ants, ticks, and chiggers, and it claims to stop pain, relieve itching, and reduce infection. The last line of the text is not legible.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.